£18m Galen 攻撃する,衝突するs a 頂点(に達する)

?

株 in Galen 急に上がるd 55p to an 史上最高 of 662 1/2p today after the Northern Irish 麻薬s group produced sparkling 利益(をあげる) 人物/姿/数字s and held out the prospect of more to come.

The group, which a year ago failed in its 試みる/企てる to 完全にする a £1 billion 合併 with the 私的な Dutch group Ferring 製薬のs, unv eiled a 55% jump in pre-税金 利益(をあげる)s to £18.4 million in the year to September. A final (株主への)配当 of 1.1p raises the total payout by a 4半期/4分の1 to 1.65p.

Chairman Allen McClay said the company had continued to 配達する on the 戦略 輪郭(を描く)d at flotation in 1997.

The comparisons were flattered by a £2.73 million 告発(する),告訴(する)/料金 last time for the 中止するd 合併. Stripping out that, 収入s per 株 前進するd 27% to 12.03p.

The 星/主役にする sales 業績/成果 (機の)カム from the 倫理的な 製薬の services 味方する, which 供給するs outsourced 麻薬s 実験(する)ing services for larger 麻薬s companies. Turnover there 前進するd 72% to £28.4 million, while the branded 倫理的な 麻薬s 商売/仕事 was up 19% at £38.6 million.

{"status":"error","code":"499","payload":"資産 id not 設立する: readcomments comments with assetId=1575297, assetTypeId=1"}